MARKET INDEX
KOSPI4,968.48▼ 2.59%
KOSDAQ650.06▼ 7.09%
S&P 5007,416.59▼ 1.92%
NASDAQ24,509.76▼ 2.49%
USD/KRW1,337.87▲ 2.05 (+0.15%)
WTI Crude$85.39▼ 0.38%
BTC/USD$64,574▼ 0.39%
KOSPI4,968.48▼ 2.59%
KOSDAQ650.06▼ 7.09%
S&P 5007,416.59▼ 1.92%
NASDAQ24,509.76▼ 2.49%
USD/KRW1,337.87▲ 2.05 (+0.15%)
WTI Crude$85.39▼ 0.38%
BTC/USD$64,574▼ 0.39%
헤더 좌
헤더 우
BREAKING
MARKET Times 공식 배너

Former Samsung and Lotte Bio Executives Reunite at HLB to Drive Commercialization

Key industry veterans who led the establishment of Samsung and Lotte Biologics have joined HLB to accelerate global drug commercialization and manufacturing efficiency.

Former Samsung and Lotte Bio Executives Reunite at HLB to Drive Commercialization
MTIMES Archive / Photo

Key industry veterans who led the establishment of Samsung and Lotte Biologics have joined HLB to accelerate global drug commercialization and manufacturing efficiency.

MARKET Times

MTIMES Global Editorial Statement

This analysis is provided for international business intelligence and informational purposes only. It does not constitute investment advice or a solicitation to buy or sell securities. For inquiries regarding licensing or syndication, please contact [email protected].

← More in CorporateBack to Top ↑

Related Market & Corporate Intelligence

Brokerages Temper KOSPI Expectations Amid Market VolatilityBrokerages Temper KOSPI Expectations Amid Market VolatilitySamsung and SK Hynix Face Antitrust Scrutiny in U.S. Over DRAM Supply StrategiesSamsung and SK Hynix Face Antitrust Scrutiny in U.S. Over DRAM Supply StrategiesGlobal Oil Market Divergence: Crude Surplus Meets Persistent Diesel TightnessGlobal Oil Market Divergence: Crude Surplus Meets Persistent Diesel TightnessFed's Warsh Warns of Employment Shocks Amid AI Growth ExpectationsFed's Warsh Warns of Employment Shocks Amid AI Growth Expectations
HomeTOP10AlmatenPicksCorpAlgiten